What is StatRad?
StatRad operates as a specialized provider of teleradiology solutions, functioning as a critical extension for radiology groups seeking to optimize their diagnostic workflows. Since 1995, the company has cultivated a reputation for delivering 24/7/365 non-predatory quality services, ensuring that healthcare providers have access to swift, accurate reporting regardless of time or location. By integrating advanced technology with a patient-centric service model, StatRad effectively addresses the industry's need for reduced diagnostic discrepancies and lower operational costs.
The company's market position is defined by its focus on secure, scalable systems that support the complex requirements of modern radiology departments. Through its commitment to superior patient care and reliable results, StatRad has established itself as a trusted partner in the rapidly evolving field of medical imaging, consistently delivering value to its network of clinical collaborators.
How much funding has StatRad raised?
StatRad has raised a total of $42.2M across 2 funding rounds:
Private Equity
$29.2M
Unspecified
$13M
Private Equity (2016): $29.2M, investors not publicly disclosed
Unspecified (2016): $13M, investors not publicly disclosed
Key Investors in StatRad
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for StatRad?
With the successful closure of this major strategic investment, StatRad is poised to enter a new phase of enterprise-level expansion. The company is expected to leverage these resources to enhance its proprietary technology stack, further reducing turnaround times and improving the precision of diagnostic reporting. Strategic priorities likely include the scaling of its teleradiology network to meet the increasing demand for remote diagnostic support in hospital systems and private practices alike.
Furthermore, the capital will likely facilitate deeper investments in cybersecurity and data integrity, ensuring that StatRad remains at the forefront of secure medical information exchange. As the healthcare industry continues to shift toward digital-first diagnostic models, StatRad's focus on sustainable, high-quality service delivery positions it to capture additional market share and drive long-term value for its stakeholders.
